Safeguarding Indigenous Knowledge Against Biopiracy in the Era of Globalisation

For generations, indigenous communities around the world have cultivated an intimate relationship with their natural environments – developing medicines from plants, farming techniques from seeds, and healing practices passed down through oral tradition. This body of knowledge, built over centuries, is not just practical; it is cultural identity. But in the age of globalisation, this knowledge has become a target. Multinational corporations, armed with legal teams and laboratory equipment, have increasingly tapped into indigenous biological resources and traditional knowledge – and then locked communities out through patents. This practice is known as biopiracy, and understanding it requires examining the intersection of intellectual property law, economic power, and the rights of the world’s most marginalised peoples.

What is biopiracy? 🔗

Biopiracy is the unauthorised appropriation of knowledge and genetic resources from farming and indigenous communities by individuals or institutions seeking exclusive monopoly control through patents or intellectual property rights. It differs from simple theft in that it operates within – and is often enabled by – existing legal frameworks. Corporations legally patent compounds or processes derived from biological materials and traditional knowledge without obtaining meaningful consent or sharing benefits with the communities whose generations of observation and practice made those discoveries possible. The term was coined in the 1990s by environmentalist Pat Mooney to describe a practice in which indigenous knowledge of nature is used by others for profit, without authorisation or compensation.

It is worth distinguishing biopiracy from bioprospecting, which in its ethical form involves exploring natural resources for useful compounds and sharing the resulting benefits fairly. The problem arises when bioprospecting becomes exploitative – when corporations use local knowledge as a roadmap into the lab, and then patent what they find without acknowledging, let alone rewarding, the source.

How the patent system enables exploitation 🔗

The intellectual property system, as it stands, is structurally misaligned with how indigenous knowledge works. Patent law is built on monopolistic and exclusionary rights, while indigenous communities emphasise collective benefit and the needs of the group over individual ownership. For these communities, owning a constantly evolving organism – or assigning rights over knowledge that belongs to an entire people – is not just illogical but culturally harmful.

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), enforced through the World Trade Organization, requires member countries to develop legal frameworks protecting plant and animal varieties. But in practice, this has meant that corporations from wealthy nations can patent biological compounds derived from knowledge held by communities in biodiversity-rich developing nations – without those communities having any legal standing to challenge the claim. As one analysis notes, the burden of proof lies on the affected community, which often does not possess the resources or legal knowledge to contest the claims.

Compounding the problem, the TRIPS agreement requires that an innovation be capable of generating industrial profit to qualify for intellectual property protection, which systematically excludes knowledge that serves social or communal needs. This effectively shifted the intellectual commons from common rights to private rights, encouraging corporate monopoly over the very building blocks of life.

Real cases: when traditional knowledge was patented 🔗

The neem tree, India 🔗

Perhaps the most cited example of biopiracy involves India’s neem tree, which has been used by rural farmers for over 2,000 years as an insecticide, medicinal treatment, and agricultural aid. In 1994, the US Department of Agriculture and the corporation W.R. Grace received a European patent on methods of controlling fungal infections in plants using a neem-derived compound. The India-based Research Foundation for Science, Technology and Ecology challenged the patent, arguing that the properties of the neem tree were already well-known traditional knowledge and therefore not novel. The patent was finally overturned by the European Patent Office in 2000, but the battle took years and significant resources. The neem tree has since become a symbol of indigenous resistance against transnational intellectual property overreach.

Turmeric and basmati rice 🔗

Turmeric was patented by the University of Mississippi in 1995 for its wound-healing properties – a use that had been documented in Indian Ayurvedic medicine for centuries. India successfully challenged this patent by presenting ancient Sanskrit texts as evidence that the knowledge was not new. Similarly, the American company RiceTec attempted to patent basmati rice varieties, threatening the livelihoods of South Asian farmers whose communities had developed and cultivated the grain for generations. These cases illustrate a recurring pattern: corporations identify traditional uses through indigenous knowledge, introduce minor modifications in a laboratory setting, and file patents that then give them exclusive commercial rights.

The Maya and French Guiana 🔗

Biopiracy is not limited to South Asia. In French Guiana, French researchers documented local antimalarial remedies using the plant Quassia amara. A decade later, a patent was granted for a compound derived from that plant. While the researchers argued that their laboratory extraction method differed from traditional preparations, it was the local Guianans and their plant knowledge that led the scientists to examine the plant in the first place. In Mexico, the Maya ICBG controversy of 1999-2000 became one of the first high-profile cases to draw global attention to the problem of distinguishing ethical bioprospecting from exploitative biopiracy, particularly around the issue of prior informed consent.

The ethical and economic stakes for indigenous communities 🔗

The harms of biopiracy are not merely symbolic. Without proper compensation for traditional knowledge, the sudden increase in commercial value of a species can make it unaffordable for the native people who originally relied on it. In some cases, patents filed by external companies can prohibit indigenous communities from even using or selling the very resource that has been part of their culture for generations. For farmers, the consequences are especially severe: corporate patents over seeds mean that exchanging seeds – a practice central to agricultural communities worldwide – can become a legal violation.

Beyond the economic losses, there is a deeper ethical dimension. Biopiracy is described as a “silent disease” because it is hardly detectable and does not leave frequent traces. Unlike deforestation or pollution, which can be photographed and reported, the theft of intellectual and biological heritage is largely invisible. This invisibility makes it harder to mobilise public attention and harder for communities to mount legal challenges without significant external support.

Developing countries are disproportionately affected because they tend to be rich in biodiversity and traditional knowledge but lack the robust legal infrastructure, financial resources, and political influence needed to monitor and challenge patent claims in international courts. The imbalance of power between a multinational pharmaceutical or agrochemical company and a rural indigenous community is rarely more starkly visible than in these disputes.

International responses: from the CBD to the WIPO Treaty 🔗

The Convention on Biological Diversity and the Nagoya Protocol 🔗

The Convention on Biological Diversity (CBD), which entered into force in 1993, was a landmark step in recognising that sovereign nations – particularly biodiversity-rich developing countries – hold rights over their genetic resources. It introduced the principle of prior informed consent: bioprospectors must obtain permission before accessing resources, and any resulting benefits must be shared equitably.

Building on the CBD, the Nagoya Protocol on Access and Benefit Sharing, adopted in 2010 and entering into force in 2014, created a more concrete framework. It mandates the fair and equitable sharing of benefits arising from the use of genetic resources provided by indigenous peoples, requiring member states to enact or amend domestic laws accordingly. The protocol encourages the development of community protocols and minimum requirements for benefit-sharing agreements. As of August 2025, it has been ratified by 142 parties, making it one of the most widely supported environmental agreements in this area.

The WIPO GRATK Treaty (2024) 🔗

The most significant recent development is the WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge, known as the GRATK Treaty, adopted by consensus of over 150 WIPO member states in May 2024. Following nearly 25 years of negotiations, the treaty introduces a mandatory disclosure requirement: patent applicants whose inventions are based on genetic resources or associated traditional knowledge must disclose the country of origin of those resources and identify the indigenous peoples or local communities that provided relevant knowledge.

This is the first WIPO treaty to include provisions specifically for indigenous peoples. By recognising genetic heritage and the knowledge of local peoples and indigenous communities, the treaty aims to improve the transparency, fairness, and quality of the global patent system. However, critics note that the disclosure requirement is not retroactive – it does not apply to patents already granted – and that a treaty without strong enforcement mechanisms would do little to rein in biopiracy and patent fraud. Indigenous representatives have also pointed out that the treaty’s provisions still require endorsement by member states to be meaningfully incorporated into negotiations, leaving indigenous peoples somewhat peripheral to decisions about their own heritage.

The deeper issue: collective rights in a system built for individuals 🔗

At the heart of the biopiracy debate is a fundamental mismatch between two worldviews. Western intellectual property law is built around the individual inventor: it asks who made a discovery, grants rights to that person or corporation, and measures value in terms of commercial profitability. Indigenous knowledge systems are built around collective stewardship: knowledge is held communally, developed across generations, and inseparable from land, culture, and identity.

This mismatch means that even well-intentioned reforms struggle to fully protect indigenous interests. Databases of traditional knowledge – one proposed tool for establishing “prior art” to block spurious patents – raise their own concerns about who controls the data and who benefits from making indigenous knowledge publicly accessible. The WIPO treaty itself acknowledges the importance of indigenous data sovereignty but stops short of resolving how information systems should be governed.

What remains clear is that protecting indigenous knowledge against biopiracy is not merely a legal or economic question. It is a question of justice – of whether globalisation will continue to extract value from the world’s most marginalised communities without accountability, or whether a genuinely equitable framework can be built. As the ethical, social, and political issues surrounding bioprospecting are increasingly recognised, the demand grows louder that indigenous peoples be not just consulted, but empowered as decision-makers over the knowledge and resources that are rightfully theirs.

What do you think? Should multinational corporations that have profited from patents based on indigenous knowledge be required to retroactively compensate the communities whose knowledge they used – even before the WIPO GRATK Treaty comes into force? And can a legal system built around individual invention ever truly protect knowledge that is inherently collective?

References

1. https://en.wikipedia.org/wiki/Biopiracy
2. https://ipmall.law.unh.edu/sites/default/files/hosted_resources/PLANT_PATENT_ARTICLES/biopiracy_and_indigenous_knowledges.pdf
3. https://www.wto.org/english/tratop_e/trips_e/trips_e.htm
4. https://synergeticpress.com/blog/sustainability-ecology/biopiracy-corporations-patent-nature/
5. https://www.rfste.org/
6. https://theconversation.com/biopiracy-when-indigenous-knowledge-is-patented-for-profit-55589
7. https://en.wikipedia.org/wiki/Bioprospecting
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC7910072/
9. https://www.vedantu.com/biology/biopiracy
10. https://www.cbd.int/
11. https://www.cbd.int/abs/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC11959332/
13. https://en.wikipedia.org/wiki/Nagoya_Protocol
14. https://www.wipo.int/en/web/traditional-knowledge/wipo-treaty-on-ip-gr-and-associated-tk
15. https://www.wilmerhale.com/en/insights/client-alerts/20240826-wipo-adopts-treaty-on-intellectual-property-genetic-resources-and-associated-traditional-knowledge
16. https://www.dlapiper.com/en/insights/publications/2024/06/wipo-new-treaty-on-intellectual-property
17. https://theconversation.com/patents-based-on-traditional-knowledge-are-often-biopiracy-a-new-international-treaty-will-finally-combat-this-231272